These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33671590)
1. Development of Genome Editing Approaches against Herpes Simplex Virus Infections. Zhang I; Hsiao Z; Liu F Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590 [TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483 [TBL] [Abstract][Full Text] [Related]
3. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections. Chen YC; Sheng J; Trang P; Liu F Viruses; 2018 May; 10(6):. PubMed ID: 29844277 [TBL] [Abstract][Full Text] [Related]
4. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9. Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM Elife; 2019 Dec; 8():. PubMed ID: 31789594 [TBL] [Abstract][Full Text] [Related]
5. Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro. Li Y; Wei Y; Li G; Huang S; Xu J; Ding Q; Hong J Transl Vis Sci Technol; 2022 Feb; 11(2):8. PubMed ID: 35119473 [TBL] [Abstract][Full Text] [Related]
6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
7. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems. Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174 [TBL] [Abstract][Full Text] [Related]
8. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors. Khodadad N; Fani M; Jamehdor S; Nahidsamiei R; Makvandi M; Kaboli S; Teimoori A; Thekkiniath J Folia Histochem Cytobiol; 2020; 58(3):174-181. PubMed ID: 32937678 [TBL] [Abstract][Full Text] [Related]
17. Gene editing and elimination of latent herpes simplex virus in vivo. Aubert M; Strongin DE; Roychoudhury P; Loprieno MA; Haick AK; Klouser LM; Stensland L; Huang ML; Makhsous N; Tait A; De Silva Feelixge HS; Galetto R; Duchateau P; Greninger AL; Stone D; Jerome KR Nat Commun; 2020 Aug; 11(1):4148. PubMed ID: 32811834 [TBL] [Abstract][Full Text] [Related]
18. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases]. Yin LJ; Hu SQ; Guo F Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428 [TBL] [Abstract][Full Text] [Related]
19. Viral DNA Sensors IFI16 and Cyclic GMP-AMP Synthase Possess Distinct Functions in Regulating Viral Gene Expression, Immune Defenses, and Apoptotic Responses during Herpesvirus Infection. Diner BA; Lum KK; Toettcher JE; Cristea IM mBio; 2016 Nov; 7(6):. PubMed ID: 27935834 [TBL] [Abstract][Full Text] [Related]
20. HSV-1 tegument protein and the development of its genome editing technology. Xu X; Che Y; Li Q Virol J; 2016 Jun; 13():108. PubMed ID: 27343062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]